These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

514 related items for PubMed ID: 7822316

  • 21. A novel FK506 binding protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor.
    Lam E, Martin MM, Timerman AP, Sabers C, Fleischer S, Lukas T, Abraham RT, O'Keefe SJ, O'Neill EA, Wiederrecht GJ.
    J Biol Chem; 1995 Nov 03; 270(44):26511-22. PubMed ID: 7592869
    [Abstract] [Full Text] [Related]

  • 22. Structure-activity studies of rapamycin analogs: evidence that the C-7 methoxy group is part of the effector domain and positioned at the FKBP12-FRAP interface.
    Luengo JI, Yamashita DS, Dunnington D, Beck AK, Rozamus LW, Yen HK, Bossard MJ, Levy MA, Hand A, Newman-Tarr T.
    Chem Biol; 1995 Jul 03; 2(7):471-81. PubMed ID: 9383449
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. FAP48, a new protein that forms specific complexes with both immunophilins FKBP59 and FKBP12. Prevention by the immunosuppressant drugs FK506 and rapamycin.
    Chambraud B, Radanyi C, Camonis JH, Shazand K, Rajkowski K, Baulieu EE.
    J Biol Chem; 1996 Dec 20; 271(51):32923-9. PubMed ID: 8955134
    [Abstract] [Full Text] [Related]

  • 33. Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling.
    Abraham RT.
    Curr Opin Immunol; 1998 Jun 20; 10(3):330-6. PubMed ID: 9638370
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Dominant mutations confer resistance to the immunosuppressant, rapamycin, in variants of a T cell lymphoma.
    Dumont FJ, Staruch MJ, Grammer T, Blenis J, Kastner CA, Rupprecht KM.
    Cell Immunol; 1995 Jun 20; 163(1):70-9. PubMed ID: 7538911
    [Abstract] [Full Text] [Related]

  • 38. Assignment of the human FKBP12-rapamycin-associated protein (FRAP) gene to chromosome 1p36 by fluorescence in situ hybridization.
    Moore PA, Rosen CA, Carter KC.
    Genomics; 1996 Apr 15; 33(2):331-2. PubMed ID: 8660990
    [No Abstract] [Full Text] [Related]

  • 39. Rapamycin-FKBP12 blocks proliferation, induces differentiation, and inhibits cdc2 kinase activity in a myogenic cell line.
    Jayaraman T, Marks AR.
    J Biol Chem; 1993 Dec 05; 268(34):25385-8. PubMed ID: 7503980
    [Abstract] [Full Text] [Related]

  • 40. Rapamycin antifungal action is mediated via conserved complexes with FKBP12 and TOR kinase homologs in Cryptococcus neoformans.
    Cruz MC, Cavallo LM, Görlach JM, Cox G, Perfect JR, Cardenas ME, Heitman J.
    Mol Cell Biol; 1999 Jun 05; 19(6):4101-12. PubMed ID: 10330150
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.